Furthermore, the study populations in RCTs are not fully representative of patients receiving treatment for T2D in clinical practice
The FDA is a comically outdated institution
After your first month of semaglutide therapy, the Precision Peptide Genetic Test reveals how your GLP-1 receptor (rs6923761), GIPR (rs1800437), and other peptide-pathway variants influence your metabolic response
For people of reproductive age, fertility implications are worth discussing with a healthcare provider
Heres what we know from the available data thus far: No reported toxicity in preclinical injection studies No behavioral or pathological abnormalities observed No adverse safety signals in topical skin care studies Theoretical concerns about copper overload exist, but no study to date has demonstrated this outcome with GHK-Cu
What makes this particularly exciting is that inflammation lies at the heart of so many chronic conditions we see in functional medicinefrom autoimmune diseases to neurodegeneration, cardiovascular disease, and even mast cell activation syndrome